Personal information

Activities

Employment (10)

Istituto Oncologico della Svizzera Italiana: Bellinzona, TI, CH

2020-03-01 to present | Medico Consulente di Ricerca (Medical Oncology)
Employment
Source: Self-asserted source
Francesco Bertoni

Institute of Oncology Research: Bellinzona, CH

2011-10-01 to present | Institute deputy director and group leader (Lymphoma Genomics)
Employment
Source: Self-asserted source
Francesco Bertoni

Istituto Oncologico della Svizzera Italiana: Bellinzona, TI, CH

2003-03-01 to 2011-09-30 | deputy director and group leader (Laboratory of Experimental Oncology)
Employment
Source: Self-asserted source
Francesco Bertoni

Barts and The London School of Medicine and Dentistry: London, London, GB

1999-10-01 to 2003-02-28 | visiting research fellow (Department of Experimental Haematology )
Employment
Source: Self-asserted source
Francesco Bertoni

Istituto Oncologico della Svizzera Italiana: Locarno, TI, CH

1999-04-01 to 1999-09-30 | visiting research fellow (Laboratory of Experimental Oncology)
Employment
Source: Self-asserted source
Francesco Bertoni

Istituto Di Ricerche Farmacologiche Mario Negri: Milano, Lombardia, IT

1998-04-16 to 1999-03-31 | research fellow and civil service (Molecular Pharmacology Unit, Department of Oncology )
Employment
Source: Self-asserted source
Francesco Bertoni

University College London Institute of Child Health: London, London, GB

1998-01-01 to 1998-04-15 | visiting research fellow (Molecular Haematology Unit)
Employment
Source: Self-asserted source
Francesco Bertoni

Ospedale Regionale di Locarno: Locarno, CH

1996-01-01 to 1997-12-31 | Specialty research fellow (Medical Oncology Department and Bone Marrow Transplantation Laboratory, Servizio Oncologico Cantonale )
Employment
Source: Self-asserted source
Francesco Bertoni

Ospedale Maggiore Policlinico: Milano, Lombardia, IT

1995-02-01 to 1995-12-31 | Specialty School fellow (Service of Medical Oncology )
Employment
Source: Self-asserted source
Francesco Bertoni

San Raffaele Hospital: Milan, IT

1991-11-01 to 1995-01-31 | attending student (Division of Medicine II )
Employment
Source: Self-asserted source
Francesco Bertoni

Education and qualifications (5)

Università della Svizzera Italiana: Lugano, TI, CH

2019-02-01 to present | Adjunct Professor (Faculty of Biomedical Sciences)
Qualification
Source: Self-asserted source
Francesco Bertoni

Université de Lausanne: Lausanne, CH

2012-05-01 to 2018-12-31 | authorized Thesis Director
Qualification
Source: Self-asserted source
Francesco Bertoni

University of Zurich: Zurich, CH

2015-06-01 to 2015-06-05 | FELASA Category B LTK module 1
Qualification
Source: Self-asserted source
Francesco Bertoni

Università degli Studi di Milano: Milano, Lombardia, IT

1994-10-01 to 1998-11-10 | Post-graduated in Oncology (Specialty School of Oncology)
Education
Source: Self-asserted source
Francesco Bertoni

Università degli Studi di Milano: Milano, Lombardia, IT

1988-09-01 to 1994-07-26 | Medical Doctor (Faculty of Medicine)
Education
Source: Self-asserted source
Francesco Bertoni

Professional activities (15)

Springer Nature: Strassen, Luxembourg, LU

2020-02-01 to present | Member of the Editorial Board of Clinical Epigenetics
Service
Source: Self-asserted source
Francesco Bertoni

MDPI AG: Basel, BS, CH

2020-01-01 to present | Member of the Editorial Board of Cancers
Service
Source: Self-asserted source
Francesco Bertoni

International Conference on Malignant Lymphoma: Bellinzona, CH

2019-10-01 to present | President Local Organizing Committee of the International Conference on Malignant Lymphoma
Service
Source: Self-asserted source
Francesco Bertoni

Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung: Bern, Bern, CH

2016-06-15 to present | Vice-president of the Project Group
Service
Source: Self-asserted source
Francesco Bertoni

Chinese Anti-Cancer Association: Tianjin, CN

2013-12 to present | Member of the Editorial Board of Cancer Biology & Medicine
Service
Source: Self-asserted source
Francesco Bertoni

Wiley Blackwell: Oxford, Oxfordshire, GB

2008-01-01 to present | Editor-in-Chief of Hematological Oncology
Service
Source: Self-asserted source
Francesco Bertoni

Taylor and Francis Group: Abingdon, Oxfordshire, GB

2007-06-01 to present | Member of the Editorial Board of Leukemia and Lymphoma
Service
Source: Self-asserted source
Francesco Bertoni

Ministero dell'Istruzione dell'Università e della Ricerca: Roma, Lazio, IT

2017-07-20 | Abilitazione Scientifica Nazionale 2020-2023 alle funzioni di Professore Universitario di Prima Fascia, Bando D.D. 1532/2016, Settore Concorsuale 06/D3 “Malattie del Sangue, Oncologia e Reumatologia”
Distinction
Source: Self-asserted source
Francesco Bertoni

Elsevier Ltd: London, London, GB

2013-01-01 to 2014-12-31 | Lymphoma co-Editor of the “Leukaemia & Lymphoma” website
Service
Source: Self-asserted source
Francesco Bertoni

Wiley Blackwell: Oxford, Oxfordshire, GB

2005-02-01 to 2007-12-31 | Associate Editor of Hematological Oncology
Service
Source: Self-asserted source
Francesco Bertoni

Barts and The London School of Medicine and Dentistry: London, London, GB

2002-02-01 to 2003-01-30 | Honorary Senior Lecturer
Invited position
Source: Self-asserted source
Francesco Bertoni

San Salvatore Foundation: Agno, CH

2002-04-15 | Young Investigators Award
Distinction
Source: Self-asserted source
Francesco Bertoni

Swiss Bridge Foundation: zurich, CH

2002-01-15 | Swiss Bridge Award
Distinction
Source: Self-asserted source
Francesco Bertoni

Krebsforschung Schweiz: Bern, CH

2000-01-01 | 2-years fellowship
Distinction
Source: Self-asserted source
Francesco Bertoni

Schweizerisches Institut für Angewandte Krebsforschung (SIAK) / Pharmacia, Upjohn: Bern, CH

1998-08-15 | 1998 Prize
Distinction
Source: Self-asserted source
Francesco Bertoni

Funding (30)

Genetic screening of enhancer RNAs to understand their causative biological role in refractory diffuse large B cell lymphoma

2020-06 to 2023-05 | Grant
NCCR RNA & Disease (Bern, CH)
Source: Self-asserted source
Francesco Bertoni

An integrated approach to identify the mechanism of resistance to copanlisib and venetoclax in marginal zone lymphoma

2019-08 to 2022-07 | Grant
Swiss Cancer Research (Bern, CH)
Source: Self-asserted source
Francesco Bertoni

Finding a way to by-pass the resistance to PI3K inhibitors in marginal zone lymphomas

2019-06 to 2020-05 | Grant
Fondazione Ticinese per la Ricerca sul Cancro (Bellinzona, CH)
Source: Self-asserted source
Francesco Bertoni

An implantable device to tailor treatment in patients with lymphoma

2017-04 to 2019-03 | Grant
Fondazione Leonardo (Lugano, CH)
Source: Self-asserted source
Francesco Bertoni

Molecular prediction of long term benefit from ibrutinib in high risk chronic lymphocytic leukemia

2017-01 to 2019-12 | Grant
Schweizerischer Nationalfonds zur Förderung der wissenschaftlichen Forschung (Bern, CH)
GRANT_NUMBER: 169670
Source: check_circle
CIÊNCIAVITAE
grade
Preferred source (of 2)‎

Novel small molecule targets FLI1 in lymphoma and T-ALL

2016-10-01 to 2019-09-30 | Grant
Leukemia and Lymphoma Society (White Plains, US)
GRANT_NUMBER:

6521-17

Source: Self-asserted source
Francesco Bertoni via DimensionsWizard
grade
Preferred source (of 2)‎

Targeted agents in splenic marginal zone lymphoma: mechanisms of resistance and new combinations

2016-02-01 to 2019-01-31 | Grant
Swiss National Science Foundation (Bern, CH)
GRANT_NUMBER: 163232
Source: Self-asserted source
Francesco Bertoni via DimensionsWizard
grade
Preferred source (of 2)‎

Characterization of FLI1 as an oncogene and therapeutic target in diffuse large B-cell lymphomas

2015-08 to 2018-07 | Grant
Oncosuisse (Bern, CH)
GRANT_NUMBER:

KLS-3580-02-2015

Source: Self-asserted source
Francesco Bertoni
grade
Preferred source (of 2)‎

Identificazione di nuovi meccanismi patogenetici e nuove terapie in linfomi aggressivi pediatrici

2014-10 to 2017-09 | Grant
Fondazione Gelu (Schaan, LI)
Source: Self-asserted source
Francesco Bertoni

Functional analysis of altered transcriptional pathways in diffuse large B-cell lymphoma of the ABC subtype

2014-01 to 2017-09 | Grant
Schweizerischer Nationalfonds zur Förderung der wissenschaftlichen Forschung (Bern, CH)
GRANT_NUMBER: 147620
Source: check_circle
CIÊNCIAVITAE
grade
Preferred source (of 2)‎

Steiner Trees for Functional Analysis in Cancer System Biology

2013-09-01 to 2017-08-31 | Grant
Swiss National Science Foundation (Bern, CH)
GRANT_NUMBER: 147138
Source: Self-asserted source
Francesco Bertoni via DimensionsWizard
grade
Preferred source (of 2)‎

Anaplastic Large Cell Lymphoma: One Or More Entities?

2012-04 to 2013-03 | Grant
Anna Lisa Stiftung (Schaan, LI)
Source: Self-asserted source
Francesco Bertoni

Functional characterization of an 11q24.3 gain contributing to the pathogenesis of diffuse large B cell lymphoma by blocking B-cell maturation

2011-12 to 2013-11 | Grant
San Salvatore Foundation (Lugano, CH)
Source: Self-asserted source
Francesco Bertoni

Development of a Center of Excellence in Lymphomas at IOSI

2011-10 to 2014-09 | Grant
Fondation Nelia et Amadeo Barletta (Nyon, FR)
Source: Self-asserted source
Francesco Bertoni

The methylome of splenic marginal zone lymphoma: an integration of epigenetic, genetic and clinical data

2011-04 to 2014-03 | Grant
Jubiläumsstiftung der Schweizerischen Lebensversicherungs- und Rentenanstalt für Volksgesundheit und medizinische Forschung (Zürich, CH)
Source: Self-asserted source
Francesco Bertoni

The methylome of splenic marginal zone lymphoma: an integration of epigenetic, genetic and clinical data

2011-04 to 2013-03 | Grant
Fondazione Ticinese contro il Cancro (Bellinzona, CH)
Source: Self-asserted source
Francesco Bertoni

Computational Identification Of Pathways And Genes Involved In Lymphoid Tumors: From DNA Copy Number To Expert System

2010-08 to 2012-08 | Grant
“Ticino in Rete”-“Computational life sciences” network (Bellinzona, CH)
Source: Self-asserted source
Francesco Bertoni

Anaplastic Large Cell Lymphoma: One Or More Entities?

2009-02 to 2011-08 | Grant
Oncosuisse (Bern, CH)
GRANT_NUMBER:

02403-02-2009

Source: Self-asserted source
Francesco Bertoni
grade
Preferred source (of 2)‎

Genomic Alterations And Immunogenetics Of Richter’s Syndrome, A Diffuse Large B-Cell Lymphoma Subtype With Very Poor Prognosis

2009-02 to 2011-02 | Grant
Oncosuisse (Bern, CH)
GRANT_NUMBER:

02296-08-2008

Source: Self-asserted source
Francesco Bertoni
grade
Preferred source (of 2)‎

A Bayesian Approach for Integrated Cancer Genome Profiling 2

2008-10-01 to 2010-09-30 | Grant
Swiss National Science Foundation (Bern, CH)
GRANT_NUMBER: 121886
Source: Self-asserted source
Francesco Bertoni via DimensionsWizard
grade
Preferred source (of 2)‎

Computational Identification Of Pathways And Genes Involved In Lymphoid Tumors Starting From DNA Copy Number Analysis

2008-08 to 2010-08 | Grant
“Ticino in Rete” “Computational life sciences” network (Bellinzona, CH)
Source: Self-asserted source
Francesco Bertoni

Identification Of Prognostic Abnormalities By Genome-Wide DNA Profiling In B-Cell Chronic Lymphocytic Leukemia

2008-08 to 2010-08 | Grant
Helmut Horten Stiftung (Agno, CH)
Source: Self-asserted source
Francesco Bertoni

Identification Of Prognostic Abnormalities By Genome-Wide DNA Profiling In B-Cell Chronic Lymphocytic Leukemia

2008-08 to 2010-08 | Grant
San Salvatore Foundation (lugano, CH)
Source: Self-asserted source
Francesco Bertoni

Extranodal, Nodal And Splenic Marginal Zone B-Cell Lymphomas: How Much Are They Related To Each Other?

2007-08 to 2010-08 | Grant
Oncosuisse (Bern, CH)
GRANT_NUMBER:

02034-02-2007

Source: Self-asserted source
Francesco Bertoni
grade
Preferred source (of 2)‎

Genome Wide DNA Profiling As Outcome Predictor In Diffuse Large B Cell Lymphoma

2007-02 to 2009-02 | Grant
Oncosuisse (Bern, CH)
Source: Self-asserted source
Francesco Bertoni

A Bayesian Approach for Integrated Cancer Genome Profiling

2006-10-01 to 2008-09-30 | Grant
Swiss National Science Foundation (Bern, CH)
GRANT_NUMBER: 112430
Source: Self-asserted source
Francesco Bertoni via DimensionsWizard
grade
Preferred source (of 2)‎

Evaluation Of The Tyrosine Kinase Syk As A Possible Therapeutic Target In Lymphomas

2006-08 to 2008-08 | Grant
Oncosuisse (Bern, CH)
GRANT_NUMBER:

01835-02-2006

Source: Self-asserted source
Francesco Bertoni
grade
Preferred source (of 2)‎

Cancer Genes Involved In Genetic Progression Of Germinal Centre B Cell Lymphomas

2004-08 to 2006-08 | Grant
Oncosuisse (Bern, CH)
GRANT_NUMBER:

01517-02-2004

Source: Self-asserted source
Francesco Bertoni
grade
Preferred source (of 2)‎

Primary Central Nervous System Lymphoma: From An Improved Knowledge Of Its Peculiar Molecular And Biologic Feature Towards The Optimization Of Treatment

2004-08 to 2006-08 | Grant
Oncosuisse (Bern, CH)
GRANT_NUMBER:

01443-12-2003

Source: Self-asserted source
Francesco Bertoni
grade
Preferred source (of 2)‎

Genomic profiling on mantle cell lymphoma

2003-09 to 2004-09 | Grant
Swiss Group for Clinical Cancer Research (SAKK) (Bern, CH)
Source: Self-asserted source
Francesco Bertoni

Peer review (3 reviews for 3 publications/grants)

Review activity for Cancers. (1)
Review activity for Cell reports medicine. (1)
Review activity for Journal of the American Chemical Society. (1)